SEC Form 4 · accession 0001019687-16-004771
Medytox Solutions, Inc. · MMMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Nov 2, 2015
Accepted (ET)
Jan 11, 2016 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374536
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 2, 2015 | D | 4,600,000 | — | D | 0 | D | |
| Series B Preferred StockF2 | Nov 2, 2015 | D | 1,000 | — | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposed of pursuant to merger agreement among Medytox Solutions, Inc. ("Medytox"), CollabRx Merger Sub, Inc. ("Merger Sub") and Rennova Health, Inc. ("Rennova") (f/k/a/ CollabRx, Inc.) in exchange for 1,884,334 shares of Rennova common stock.
- F2Disposed of pursuant to merger agreement among Medytox, Merger Sub and Rennova in exchange for 1,000 shares of Rennova Series B Convertible Preferred Stock.
Remarks
Exhibit List - Exhibit 99 - Joint Filer Information